Mode
Text Size
Log in / Sign up

Autoimmune hepatitis

Part of Hepatitis

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for autoimmune hepatitis

3 trials tracked for autoimmune hepatitis: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 8 citations.

3Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 2 1 Phase 1 1
  1. Phase 4 Possible Role of Chloroquine to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial Completed · 8 cited
  2. Phase 2 A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) Completed
  3. Phase 1 sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Hepatitis

Related studies from across the Hepatitis family.

Eight-Week Sofosbuvir-Velpatasvir Matches Twelve-Week Course in Non-Cirrhotic Hepatitis C
Gastroenterology RCT
Eight-Week Sofosbuvir-Velpatasvir Matches Twelve-Week Course in Non-Cirrhotic Hepatitis C Trial shows 8-week treatment works for Hepatitis C
In 880 treatment-naive adults with non-cirrhotic hepatitis C, 8 weeks of sofosbuvir-velpatasvir achieved SVR12 rates similar to the standard…
A shorter 8-week course of sofosbuvir and velpatasvir showed similar success rates to the standard 12-week treatment for Hepatitis C patient…
HBeAg positivity and high HBV DNA levels increase postpartum ALT elevation risk in chronic hepatitis B
Primary Care & Family Medicine Meta-analysis
HBeAg positivity and high HBV DNA levels increase postpartum ALT elevation risk in chronic hepatitis B Risk Factors for Liver Inflammation in Mothers with Hepatitis B
This meta-analysis of cohort studies identifies key risk factors for postpartum alanine aminotransferase (ALT) elevation in women with chron…
Specific factors like HBeAg positivity and high viral DNA levels can increase the risk of liver inflammation in women with chronic hepatitis…
HBsAg prevalence 7.0% in dialysis patients, with low HBV-DNA and suboptimal vaccination
Infectious Disease Meta-analysis
HBsAg prevalence 7.0% in dialysis patients, with low HBV-DNA and suboptimal vaccination Hepatitis B infection rates among patients on dialysis
This meta-analysis of 79 articles estimates hepatitis B burden in dialysis patients globally. Pooled HBsAg prevalence was 7.0% (95% CI 6.1-8…
New data shows that about 7% of patients on dialysis have Hepatitis B, highlighting the need for safer procedures and better vaccination rat…
Community health workers support infectious disease management and PrEP navigation in agricultural communities
Neurology Sys. Review
Community health workers support infectious disease management and PrEP navigation in agricultural communities Community health workers help farm workers manage infectious diseases
This mini-review examines the role of community health workers (CHWs) in managing infectious diseases among California agricultural workers.…
Community health workers can help farm workers manage serious infections like HIV, tuberculosis, and hepatitis through direct outreach and n…
Hepatic macrophage metabolic reprogramming and bidirectional signaling dictate the balance between liver injury and regeneration
Gastroenterology Sys. Review
Hepatic macrophage metabolic reprogramming and bidirectional signaling dictate the balance between liver injury and regeneration New research identifies how liver cells communicate during chronic disease
This systematic review synthesizes the role of hepatic macrophages in metabolic dysfunction-associated steatotic liver disease, alcohol-asso…
New research reveals how specific immune cells in the liver switch between causing inflammation and repairing tissue damage.
Tonsillar metastasis in hepatocellular carcinoma patients may present as undifferentiated carcinoma with specific IHC markers
Oncology Sys. Review
Tonsillar metastasis in hepatocellular carcinoma patients may present as undifferentiated carcinoma with specific IHC markers Lenvatinib and Chemoembolization Treatment Linked to Liver Cancer Metastasis
This case report and literature review describes a single patient with hepatocellular carcinoma and chronic hepatitis B presenting with a to…
A rare case of liver cancer spreading to the tonsils highlights the need for careful monitoring of head and neck symptoms in patients with l…
Direct-acting antiviral therapy and diverse viral infections require comprehensive epidemiological and diagnostic strategy review
Infectious Disease Sys. Review
Direct-acting antiviral therapy and diverse viral infections require comprehensive epidemiological and diagnostic strategy review Review Outlines Treatment and Prevention for Various Viral Infections
This systematic review covers the molecular biology, epidemiology, and treatment strategies for various viral infections including Hepatitis…
A comprehensive review outlines the biological traits, diagnosis methods, and treatment strategies for several common viral infections inclu…
Global HBsAg prevalence 3.2% in nurses, with 5.6% in Africa and 3.6% in LMICs
Gastroenterology Meta-analysis
Global HBsAg prevalence 3.2% in nurses, with 5.6% in Africa and 3.6% in LMICs Nurses Face Higher Hepatitis B Risk in Poorer Countries
This meta-analysis estimates global hepatitis B surface antigen (HBsAg) prevalence among hospital-based nurses at 3.2% (95% CI 2.3-4.4), wit…
A global analysis finds 3.2% of hospital nurses carry hepatitis B, with rates four times higher in poorer countries.
Host non-coding RNAs orchestrate antiviral defense and are targeted by viral counter-defense strategies
Diabetes & Endocrinology Sys. Review
Host non-coding RNAs orchestrate antiviral defense and are targeted by viral counter-defense strategies Host molecules may help the body fight off common viruses
This systematic review examines how host non-coding RNAs, including miRNAs, lncRNAs, circRNAs, and vtRNAs, modulate antiviral responses agai…
Your body uses special molecules called non-coding RNAs to fight off viruses like flu, Zika, and COVID-19 by blocking their growth.
Incarceration acts as a structural determinant of health with higher rates of chronic and infectious diseases
Primary Care & Family Medicine Sys. Review
Incarceration acts as a structural determinant of health with higher rates of chronic and infectious diseases Incarceration Linked to Higher Rates of Mental Illness and HIV
This narrative review of 167 articles examines the health status and care utilization of incarcerated adults in Canada. It finds significant…
People in correctional centers face higher rates of mental illness and chronic diseases compared to those living in the community.
Peg-interferon add-on to nucleoside analogues achieves HBsAg loss in 8.6% of patients
Infectious Disease Meta-analysis
Peg-interferon add-on to nucleoside analogues achieves HBsAg loss in 8.6% of patients Adding peg-interferon to standard treatment helps some hepatitis B patients
This meta-analysis of 581 patients with chronic hepatitis B evaluates peg-interferon add-on to nucleoside analogue therapy. The analysis fou…
Adding peg-interferon to standard nucleoside therapy can help some patients with chronic hepatitis B achieve a key milestone in their treatm…
TZ84-based hepatitis A vaccine shows higher seroconversion rates and GMCs than HM175-based vaccine
Gastroenterology Meta-analysis
TZ84-based hepatitis A vaccine shows higher seroconversion rates and GMCs than HM175-based vaccine TZ84 vaccine shows stronger long-term protection against hepatitis A
This meta-analysis of 3,282 children and adolescents found that the TZ84-based hepatitis A vaccine is associated with higher seroconversion …
One type of hepatitis A vaccine shows higher antibody levels and longer protection in children compared to another common vaccine type.